Israel: The research and development of marijuana anticancer drugs has already been on the string

Asian countries have always controlled cannabis are the strictests in the world. On February 8 this year, the Thai government announced the formal removal of marijuana from a drug control list to become the first country in Asia to legalize. After Thailand, Israel is expected to become the next comprehensive legalization of marijuana this year.

Israel is the world leader of marijuana research, and research related to marijuana medical use has always been at the forefront of the world.

In 1964, the world's first scientist to separate the active ingredients in marijuana THC (tetrahydrology) was Raphael Merjeham from the Research Center of the University of Hebrew, Jerusalem. Since then, Israel has not stopped the use and research of marijuana.

Since the early 1990s, Israel has used marijuana for medical treatment, for cancer patients and people with pain -related diseases, such as Parkinson's disease, multiple sclerosis, Crohn disease, other chronic pain and trauma and trauma Post -stimulus disorder and so on.

In 2004, the Israeli military began to use the effective ingredients of tetrahydrology (THC) in marijuana for experimental treatment for soldiers after trauma (PTSD).

In 2017, Israel exempted most of the cannabis holding and usage, promoted related research and issued licenses to many marijuana pharmacies, and made significant progress in increasing the acceptance of marijuana.

On December 27, 2018, the Israeli Parliament passed the bill to allow export medical cannabis, allowing public service doctors to issue medical cannabis permits and prescriptions, and government -licensed pharmacies to sell medical CBDs.

On April 1, 2019, Israel uses non -guilty of adult marijuana, but individuals and commercial planting, processing, and sales are still supervised.

Earlier this year, Israel President Isaac Herzog and Minister of Justice Gideon Sa'ar announced that the government was studying the further legalization of marijuana. These laws and regulations are currently waiting for the approval of the Constitution, Law and Judicial Committee.

Israel's marijuana anti -cancer drug research and development leading the world

Israeli Biotechnology CANNABOTECH recently announced that they will establish a partnership with NXT-LVL, a California marijuana company, aiming to produce marijuana products for oncology.

In addition, the agreement will enable Cannabotech to be produced in Next-Level's facilities, in line with California's medical cannabis regulations. The company intends to promote its products to oncologists outside Israel and is expected to be listed in California in the fourth quarter of 2022.

In the past few years, Cannabotech has accumulated a lot of scientific data, and they intend to provide these data to California's cancer caregivers and doctors. These valuable information reveal the research they have completed, the purpose is to help develop marijuana drug formulas to help patients with various cancers, including pancreatic cancer, colon cancer, breast cancer, prostate and lung cancer. In addition, they are also studying the side effects of how cannabis -based treatment alleviate chemotherapy, inflammation and neurological pain.